attorney dui florida: Here are the materials you requested

To the Office of ,

Thank you for meeting with me. As a follow-up to our meeting, below are links to the materials we discussed. Please review at your leisure and feel free to contact me if you have any questions.

Download Social Media Posts. Please use the entire approved post(s) exactly as provided, without changes, in the supplied document.

Download the In-Office Video #4. Click here for the Full Prescribing Information.

View the Mechanism of Action for QWO. Click here for the Full Prescribing Information.

Download the Before & After Photos. By downloading these before and after photos ("Resources"), you agree to be bound by these Terms and Conditions.

Download the Digital Consumer Brochure.

Download the Now Available Email: Say Hello.

Download the In-Office Video #5. Click here for the Full Prescribing Information.

Download QWO FAQs. Click here for the Full Prescribing Information.

Download the QWO Fact Sheet. Click here for the Full Prescribing Information.

Download the Presentation for Patient Events. Click here for the Full Prescribing Information.

Download the In-Office Video #3. Click here for the Full Prescribing Information.

Download the In-Office Video #2. Click here for the Full Prescribing Information.

Download the Script for On-Hold Messages.

Download the Animated Website/Email Banner.

Download the QWO Product Images.

Download the Now Available Email: Meet QWO.

Download the Static Website/Email Banners.

Download the Front Desk Script. Click here for the Full Prescribing Information.

Download the In-Office Video #1. Click here for the Full Prescribing Information.

Download the Paid Search Templates.

Download Promotional Messages. Click here for the Full Prescribing Information.

For additional resources, please visit EndoIGNITE.com.

INDICATION

QWO is indicated for the treatment of moderate to severe cellulite in the buttocks of adult women.

IMPORTANT SAFETY INFORMATION FOR QWO

CONTRAINDICATIONS

QWO is contraindicated in patients with a history of hypersensitivity to collagenase or to any of the excipients or the presence of infection at the injection sites.

WARNINGS AND PRECAUTIONS

Hypersensitivity Reactions

Serious hypersensitivity reactions including anaphylaxis have been reported with the use of collagenase clostridium histolyticum. If such a reaction occurs, further injection of QWO should be discontinued and appropriate medical therapy immediately instituted. Advise patients to seek immediate medical attention if they experience any symptoms of serious hypersensitivity reactions.

Injection Site Bruising

In clinical trials, 84% of subjects treated with QWO experienced injection site bruising. Subjects with coagulation disorders or using anticoagulant or antiplatelet medications (except those taking ≤150 mg aspirin daily) were excluded from participating in Trials 1 and 2.

QWO should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet (except those taking ≤150 mg aspirin daily) or anticoagulant therapy.

Substitution of Collagenase Products

QWO must not be substituted with other injectable collagenase products.
QWO is not intended for the treatment of Peyronie's Disease or Dupuytren's Contracture.

ADVERSE REACTIONS

In clinical trials, the most commonly reported adverse reactions in patients treated with QWO with an incidence ≥ 10% were at the injection site: bruising, pain, nodule and pruritus.